Search Results - "Capdevila J"

Rapid evolution predicts demographic recovery after extreme drought.

Authors: Anstett, Daniel N. Anstett, Julia Sheth, Seema N. et al.

Source: Science. 3/12/2026, Vol. 391 Issue 6790, p1172-1176. 5p.

Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.

Authors: Capdevila J Hernando J Molina-Cerillo J et al.

Source: Nature communications [Nat Commun] 2026 Apr 04; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 04.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status.

Authors: Brose MS Keam B Krajewska J et al.

Source: Frontiers in oncology [Front Oncol] 2026 Mar 04; Vol. 16, pp. 1748566. Date of Electronic Publication: 2026 Mar 04 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.

Authors: Gomez, David Salazar, Ramón Jiménez Fonseca, Paula et al.

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 12, p4628. 12p.

A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study.

Authors: Argente-Pla M Sampedro-Nuñez MA Garcia-Carbonero R et al.

Corporate Authors: Argente-Pla M Sampedro-Nuñez MA Garcia-Carbonero R et al.

Source: Frontiers in nutrition [Front Nutr] 2026 May 26; Vol. 13, pp. 1789458. Date of Electronic Publication: 2026 May 26 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 101642264 Publication Model: eCollection Cited Medium: Print ISSN: 2296-861X (Print) Linking ISSN: 2296861X NLM ISO Abbreviation: Front Nutr Subsets: PubMed not MEDLINE

Adverse events following immunization during COVID-19 mass vaccination campaigns in the Democratic Republic of Congo: Findings from active safety surveillance.

Authors: Kayumba, Kizito Duga, Alemayehu Papa Fallah, Mosoka et al.

Source: PLoS ONE. 7/10/2026, Vol. 21 Issue 7, p1-13. 13p.

Case Report: Lorlatinib for the treatment of ALK-rearranged poorly differentiated thyroid carcinoma after progression to prior ALK-specific tyrosine-kinase inhibitor.

Authors: Yaringaño J Hernando J García-Álvarez A et al.

Source: Frontiers in oncology [Front Oncol] 2026 Mar 09; Vol. 16, pp. 1802225. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Authors: Benhima N Audisio A Gallio C et al.

Corporate Authors: Benhima N Audisio A Gallio C et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jul 02; Vol. 245, pp. 116911. Date of Electronic Publication: 2026 Jul 02.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Evolving landscape of targeted therapies in early phase clinical trials.

Authors: Rossi A Braña I Vieito M et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 03; Vol. 240, pp. 116745. Date of Electronic Publication: 2026 Apr 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Inferior Vena Cava Stenosis Mimicking Right Heart Failure in Carcinoid Heart Disease.

Authors: Vila-Sanjuán S Vallejo N Martí-Aguasca G et al.

Source: JACC. Case reports [JACC Case Rep] 2026 May 13; Vol. 31 (19), pp. 107765. Date of Electronic Publication: 2026 Apr 09.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101757292 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0849 (Electronic) Linking ISSN: 26660849 NLM ISO Abbreviation: JACC Case Rep Subsets: PubMed not MEDLINE

Sex Differences in Oxidative Stress: Role of Dietary and Nutraceutical Antioxidants and Clinical Implications.

Authors: Ventre, Alessandra Dato, Enrica Di Salvo, Marilena et al.

Source: Applied Sciences (2076-3417); Jun2026, Vol. 16 Issue 11, p5544, 19p

A Randomized clinical trial evaluating the impact on survival and quality of life of ¹⁷⁷Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

Authors: Capdevila J Pubul V Anido U et al.

Source: BMC cancer [BMC Cancer] 2025 Apr 04; Vol. 25 (1), pp. 613. Date of Electronic Publication: 2025 Apr 04.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK).

Authors: Hernando J Lopez C Garcia-Alvarez A et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Mar 11; Vol. 236, pp. 116252. Date of Electronic Publication: 2026 Jan 23.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.

Authors: Nakamura, Teruo Shibata, Tomohiro Ito, Ken-ichi

Source: PLoS ONE. 3/5/2026, Vol. 21 Issue 3, p1-16. 16p.

Life-Threatening Gastrointestinal Bleeding Revealing a Rare Coexistence of Ampullary Ganglioneuroma and Pancreatic Neuroendocrine Tumor: A Case Report.

Authors: Mulita, Francesk Kouroupi, Maria Verras, Georgios-Ioannis et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1778. 12p.

Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells.

Authors: Däubler, Christof Böttcher, Clara Landwehr, Laura-Sophie et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1368. 13p.

[¹⁷⁷Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Authors: Walter T Jann H Ansquer C et al.

Corporate Authors: Walter T Jann H Ansquer C et al.

Source: Lancet (London, England) [Lancet] 2026 Jul 18; Vol. 408 (10551), pp. 234-247. Date of Electronic Publication: 2026 Jul 02.

Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial; Equivalence Trial

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Authors: Schultheiß C Besemer B Willscher E et al.

Source: Communications medicine [Commun Med (Lond)] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond)

Recent evolution of the developing human intestine affects metabolic and barrier functions.

Authors: Yu, Qianhui Kilik, Umut Secchia, Stefano et al.

Source: Science. 8/21/2025, Vol. 389 Issue 6762, p1-13. 13p.

Thyroid lesions of neuroendocrine origin? Thinking of a "polka‐dotted" zebra! Case series from three Italian referral centers and review of the literature.

Authors: Feola, Tiziana Cozzolino, Alessia Grillo, Federica et al.

Source: Journal of Neuroendocrinology. Sep2025, Vol. 37 Issue 9, p1-15. 15p.